HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 205 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,552 | +0.1% | 10,026 | +7.5% | 0.01% | +25.0% |
| Q2 2023 | $328,182 | +5.5% | 9,326 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $311,024 | -42.7% | 9,526 | -3.3% | 0.00% | -42.9% |
| Q4 2022 | $543,066 | +25.1% | 9,856 | +0.5% | 0.01% | +16.7% |
| Q3 2022 | $434,000 | +17.0% | 9,805 | +28.9% | 0.01% | 0.0% |
| Q2 2022 | $371,000 | -11.5% | 7,605 | -11.6% | 0.01% | +50.0% |
| Q1 2022 | $419,000 | +30.5% | 8,605 | +14.2% | 0.00% | 0.0% |
| Q4 2021 | $321,000 | – | 7,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |